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Endocytosis and transcytosis of albumin gold through mice
peritoneal mesothelium
LAZARO G0TL0IB and AVSHALOM SHOSTAK
Department of Nephrology and the Komach Laborato.'y for Experimental Nephrology, Central Emek Hospital, Afula, Israel
Endocytosis and transcytosis of albumin-gold complexes through mice
peritoneal mesothelium. The present transmission electron microscopy
(TEM) study was designed to investigate whether mesothelial cells of mice
diaphragmatic, parietal and mesenteric peritoneum are actively coupled to
the mechanisms involved in the transerosal absorption of albumin gold
complexes (Alb-Au). Five albino mice were injected intraperitoneally with
0.5 ml of a suspension of Alb-Au. In three animals, in vivo fixation was
done 10 minutes after injection of Alb-Au, whereas in the remaining two,
fixation was performed 45 minutes after injection of the tracer. At both
time intervals, a substantial part of Alb-Au complexes was observed within
plasmalemmal and coated vesicles, mainly attached to the luminal aspect
of the internal luminal membranes. The amount of Alb-Au contained in
plasmalemmal vesicles was significantly higher than that detected in
intermesothelial junctions. Plasmalemmal vesicles were observed dis-
charging Alb-Au complexes in the submesothelial interstitium, showing a
significantly higher proportion of the tracer associated with non-junctional
areas. Evidence presented in this study supports the idea of local
degradation of Alb-Au in mesothelial cells after endocytosis, and that of
a continuously transcytotic mechanism transporting polymerized albumin
across the mesothelial layer. In this sense, transcytotie vesieles eould
represent the large pore equivalent.
The relevance of mesothelial cells in the transperitoneal trans-
fer of substances in and out of the abdominal cavity is still debated
[1]. Almost one century ago, it was demonstrated that absorption
of serum from serous cavities takes place at a slower rate than that
of isotonic sodium chloride solutions [2]. Then, it was postulated
that absorption is dependent on the vital activity of the cells lining
the serous cavities. This hypothesis found experimental support in
more modern in vitro and in vivo studies. It has been demon-
strated that absorption from the peritoneal cavity and transperi-
toneal passage of several small solutes are sensitive to tempera-
ture changes, drugs and metabolic inhibitors [3—6]. However, the
mechanisms and pathways governing the peritoneal absorption of
albumin from the peritoneal cavity have not been completely
identified, in spite of the profuse published literature dealing with
this specific subject. It has been proposed that peritoneal lymphat-
ics are the main pathway for the drainage of absorbed albumin
[7—JO]. In this context, diaphragmatic lymphatics have been
adscribed the role of channeling at least 60% of the total amount
of peritoneal fluid and albumin, drained through the right lymph
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and thoracic ducts [8, 10]. This process of absorption has been
described as occurring basically at the level of the diaphragmatic
stomata [9], originally unfolded by Von Recklinghausen. How-
ever, the amount of lymph drained through visceral and parietal
peritoneal lymphatics is still ill defined [11]. Furthermore, recent
information [12, 13] suggests that peritoneal lymphatics may not
play an exclusive role in the transport of absorbed albumin to the
venous circulation.
The role of the mesothelial layer in the phenomenon of
absorption has been considered both extremely important [1, 4, 6]
and irrelevant [12]. Facing this controversy, we decided to inves-
tigate whether mesothelial cells of mouse diaphragmatic, parietal
and mesenteric peritoneum are actively coupled to the mecha-
nisms leading to the transerosal absorption of albumin. From the
variety of techniques which have been applied to study localiza-
tion of cellular macromolecules, we chose albumin gold com-
plexes. This tracer is an electron-dense, non-cytotoxic and stable
cytochemical marker [14]. Even though the nature of macromo-
lecular binding to gold is largely unknown, it has been demon-
strated that it is irreversible [15]. This technique has also been
recently used to study in vivo endocytosis by endothelial cells of
bone marrow sinusoid capillaries [16].
Therefore, bovine serum albumin gold complexes (Alb-Au)
were used for detecting, by means of transmission electron
microscopy (TEM), the transmesothelial transport of macromo-
lecular proteins.
Methods
Five apparently healthy albino male mice, weighing 21 to 24 g,
were intraperitoneally (i.p.) injected with 0.5 ml of albumin
(bovine-biotin amido caproyl labeled) adsorbed to colloidal gold
(Sigma) (Alb-Au complexes). Gold mean particle diameter esti-
mated by TEM was 9.1 0.7 nm (± sn) (coefficient of variation:
7.3%), according to data obtained by the manufacturer after
measuring 100 gold particles. The average diameter of this
polymeric albumin-gold complex is approximately of 14.4 nm [17].
The suspension was prepared in 50% glycerol containing 0.15 M
NaCI, 0.01 M phosphate buffer, 5 mg/mi albumin, 0.05% Tween 20
at pH 7.0, and the number of particles was of 4.1 >< 1013/ml.
After a dwell time of 10 minutes, in vivo fixation of the
peritoneum was carried out under ether anesthesia, injecting 5 ml
of Karnovsky fixative [18] intraperitoneally. This solution was left
to dwell for a period of 10 minutes, by the end of which samples
of parietal, diaphragmatic and mesenteric peritoneum were sur-
gically taken, after laparotomy, from each one of three animals. In
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the other two, the Alb-Au suspension was left to dwell for 45
minutes, and only thereafter was the procedure of in vivo perito-
neal fixation carried out. Damage by handling the mesothelial
surface was carefully avoided.
Tissue samples were sectioned to pieces of approximately 1
mm3. Fixation was done by 2% formaldehyde and 2.5%glutaral-
dehyde in 0.1 M sodium cacodylate buffer at pH 7.2 and at a
temperature of 4°C overnight. After rinsing in the same buffer, the
samples were post-fixed in 2% osmium tetroxide for one hour,
then dehydrated in ethanol and embedded in Epon 812. Three to
four blocks from each examined peritoneal portion (mesentery,
parietal and diaphragmatic peritoneum) were prepared. Conse.
quently, 9 to 12 blocks were prepared from each mouse, making a
total number of 51 blocks (28 from the 10-mm dwell time, and 23
from the 45-mm dwell animals).
Preliminary 1 .tm semithin sections were cut from each block,
stained with 1% toluidine blue, and examined by light microscopy.
Areas containing mesothelium, blood and lymphatic capillaries
were identified, and ultrathin sections were cut on a diamond
knife using an LKB 4804 A ultramicrotome, mounted on copper
grids, stained with lead citrate, and examined in a Phillips 300
electron microscope at 60 Ky.
The number of examined grids ranged between 4 and 5 per
block, making a total number of 234 grids: 130 from the 10-minute
dwell group, and 104 from the group where the dwell time of
Alb-Au was 45 minutes.
For morphometric purposes, 25 electron micrographs (approx-
imately 1 per block) were taken from the mesothelium covering
the cavitary surface of each one of the explored peritoneal
portions (mesentery, diaphragmatic and parietal peritoneum).
Prints were enlarged to achieve a final magnification of x41,500.
Both length of the mesothelial cell's plasma membrane facing the
abdominal cavity and surface area of cells cytoplasm appearing in
the electron micrographs were measured by planimetry. Other
measurements on the prints were made using a vernier caliper
(accurate to 0.01 mm) and a hand magnifying lens.
Mean thickness of sectioned mesothelial and endothelial cells
was calculated from measurements taken every 10 mm along the
prints (so far, 10 mm/41,500 = 0.24 Lm). Length and exposed area
of sectioned mesothelium were not significantly different in both
groups of data (10 and 45 mm samples). The same can be stated
for the individual contribution of each peritoneal portion to the
total figures.
For the 10 minute samples, length of the examined mesothelial
luminal border was 200.16 m (mesentery, 71.45 itm; diaphrag-
matic mesothelium, 78.46 jim; parietal peritoneum, 50.25 gm),
and the mean cellular thickness was 0.71 0.38 m (mesentery,
0.68 0.62 .tm; diaphragmatic mesothelium, 0.59 0.31 m; and
parietal peritoneum, 0.86 0.10 gm).
For samples obtained 45 minutes after the injection of Alb-Au,
the total luminal length was 165,80 .tm (mesentery, 50.26 urn;
diaphragm, 63.37 urn; parietal peritoneum, 52.17 1km), whereas
mean cell thickness was 0.67 0.41 urn (mesentery, 0.55 0.19
um; diaphragm, 0.77 0.61 j.tm; parietal peritoneum, 0.69 0.43
rn).
The total area of transversal sections of mesothelial cells shown
in the 10 minute sections was 138.17 jLm2 (mesentery, 48.61 urn2;
diaphragmatic mesothelium, 46.31 um2; parietal peritoneum,
43.25 p.m2). The total area assessed in mesothelial sections
obtained 45 minutes after the intraperitoneal injection of Alb-Au
Table 1. Total numbers of Mb-Au particles observed in different parts
of the peritoneal samples obtained from the 10 and the 45 minute dwell
time groups
Samples 10 mm 45 mm P
Total number of observed 1729 949
Mb-Au particles
Mb-Au on glycocalyx 248 (14.34%) 53 (5.58%) <0.001
Alb-Au into tight junctions (3.76%) (0.53%) <0.01
(percent of extracellular
Alb-Au particles)
Number of tight junctions 10/37 (27.03%) 3/34 (8.82%) <0.001
with Mb-Au (% of TI)
Intracellular Mb-Au 1252 (72.41%) 796 (83.88%) <0.001
Unless specified differently, numbers between parentheses indicate the
percentage of the total number of observed Mb-Au particles.
complexes was 118.39 urn2 (mesentely, 31.06 gm2; diaphragmatic
mesothelium, 50.25 urn2; and parietal peritoneum, 37.07 1km2).
Thirty more photographs showing lymphatic capillaries were
obtained on samples taken from diaphragmatic peritoneum: 15 at
10 minutes, and the other 15 at 45 minutes after i.p. injection of
the Alb-Au complexes. Final prints were enlarged at X41,500.
The total luminal length of the examined lymphatic endothe-
hum was 66.75 um for the 10 minute samples, whereas for the 45
minute observations, figures were 50.27 urn. Mean endothelial
cell thickness for the 10 and the 45 minute dwell time groups were
0.38 0.24 urn and 0.32 0.18 urn, respectively. The exposed
area of sectioned lymphatic endothelium was 27.20 urn2 in the 10
minute samples, and 17.55 urn2 for the 45 minute specimens. Ten
more electronmicrographs were taken from blood microvessels at
each time interval.
Values are presented as mean standard deviation. Compar-
ison between two percentages was performed according to the
following formula:
P1 — P2
- P)[(1/nl) + (1I)]
Whereas:P11 = al ' P2,,= a2
al and a2 are the observed percentages in groups 1 and 2,
respectively, and ni and n2 are number of cases in each group.
P al + a2 ni + n2 [19].
The level of probability "P" was obtained by looking up the
calculated value of parameter "Z" in the table of the normal
distribution. The null hypothesis was rejected at a significance
level of 0.05 (z parameter in the table of the normal distribution:
1.960).
Results
The mesothelial layer
Luminal aspect. Data presented in Table 1 indicate that the
total number of Mb-Au complexes counted in the 10 minute
samples was substantially higher than that observed at 45 minutes.
Intercellular junctions. Approximately 27% of the observed tight
junctions showed Mb-Au in the 10 minute specimens, even
though particles of the tracer were seen in the ablurninal portion
of the intercellular space in only six occasions (1.02% of extracel-
lular Alb-Au). Table 1 shows that both groups of observations
were made on an almost similar number of tight junctions.
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Fig. 1. Parietal peritoneum (10 mm after i.p.
injection of Alb-Au). Two adjoining mesothelial
cells (M, M') demarcate an intercellular space
(black stars) which contains Alb-Au complexes
in both the luminal (short straight arrow) and
the abluminal side of the channel.
Plasmalemmal vesicle (open star) is open into
the intercellular channel, through a neck
containing Alb-Au complexes (black
arrowhead). Particles of the tracer can be
noticed on the abluminal side of the
mesothelial cell (open arrowhead), within the
space limited by the cell plasmalemma and the
submesothelial basement membrane (b). One of
the cells (M') shows areas of structureless
edema (e). s is the peritoneal space. (X 87000).
Upper right inset. The same photograph is
presented at lower magnification to give a
better look of the luminal mesothelial cell
aspect (v is microvilli) (X 41500).
However, the absolute number and the proportion of junctions
showing Alb-Au were significantly lower in specimens taken from
the 45 minute group of animals. Indeed, in this last group, only
two particles of the tracer (1.22% of extracellular Alb-Au) were
observed in the abluminal portion of the junction. Occasionally
(Fig. 1), adjoining cells showed evidence of substantial intracel-
lular edema. This suggests some inefficiency in the homeostatic
mechanisms that maintain cell volume and electrolyte concentra-
tion gradients across the cell membrane [20, 211 and, of course, a
substantially reduced cellular vitality.
It should be noticed that the presence of Alb-Au complexes
within an intermesothelial cell junction does not necessarily imply
that the only possible pathway between cavity and interstitial
space is through the intercellular channel. Indeed, Figure 1 shows
an open plasmalemmal vesicle through the neck of which Alb-Au
complexes are discharged into the intercellular channel.
At times, particles of the tracer were seen within open inter-
cellular spaces separating two recently implanted mesothelial
cells.
Mesothelial cells. The vast majority of Alb-Au particles was
associated with the mesothelial cells. The absolute amount, as well
as the percentage of total particles contacting the glycocalyx was
significantly higher at 10 minutes (Table 1). Conversely, at 45
minutes, the percentage of particles disseminated within cells was
higher than that observed at 10 minutes (Table 1).
Populations of pinocytotic vesicles at 10 and 45 minutes were
not statistically different (818 at 10 mm, and 752 in the 45 mm
samples). Furthermore, no significant differences in the topo-
graphical distribution of pinocytotic vesicles (luminal, abluminal,
non-attached) were demonstrated.
The proportion of Alb-Au complexes included into pinocytotic
vesicles (and calculated as percentage of intracellular tracer) was
significantly higher (P < 0.01) in the 45 minute specimens
(26.67% at 10 mm, vs. 43.47% at 45 mm). In addition, numbers
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Fig. 2. Mice diaphragmatic mesothelium 10
minutes after i.p. injection of Alb-Au complexes.
Note the presence of Alb-Au complexes
(straight arrow) on the luminal aspect of an
apparenty open intermesothelial cell junction
(open arrow). The asterisks identify both
mesothelial cells. Particles of the tracer (open
circles) are between the collagen fibers (c) of
the submesothelial interstitial space.
Abbreviation and symbols are: s, abdominal
space; black star, microvilli; curved arrow,
submesothelial basement membrane (X 41500).
Upper left inset. Abluminal side of mesothelial
cell (rn) Plasmalemmal vesicle (V) shows AIb-
Au complexes lying on the luminal limiting
membrane. Curved arrow points to particles of
the tracer located in the submesothelial
interstitial space (i) (X 50720).
and proportions of the pinocytotic vesicles containing particles of
the tracer showed no significant differences when counts made on
the 10 and 45 minute samples were compared.
Alb-Au particles were considered to he attached to the luminal
aspect of the internal vesicular membrane when the distance
between both structures was less than 0.01 m. In this context,
most of the tracer appeared attached to the luminal membrane of
pinocytoticvesicles (88.32% in the 10 mm samples, and 91 .04% at
45 mm) (Fig. 2, inset). Approximately 10% of the particles
appeared randomly distributed into the lumen of plasmalemmal
vesicles (Fig. 3), suggesting the possible existence of a fluid-phase
uptake.
In the 10 minute samples, approximately 15% of vesicular
Alb-Au appeared in non-attached vesicles. This pattern was
remarkably higher in the 45 minute samples, where almost 36% of
the endocytic tracer appeared in non-attached vesicles. This value
was significantly higher (P < 0.001) than the 7.54% (4.27 +
3.27%) of Alb-Au particles present in luminal and abluminal
vesicles.
A high proportion of multivesicular bodies and endosomes
(Fig. 4, inset) (71.43% at 10 mm and 57.28% at 45 mm) contained
Alb-Au complexes. These organelles were observed near both the
luminal and the abluminal aspect of mesothelial cells. Densities at
10 and 45 minutes were not significantly different.
Most coated pits from the 10 minute samples (82%) showed
Alb-Au complexes attached to the luminal plasmalemma, whereas
at 45 minutes no such cellular organelle carrying particles of the
tracer was observed. This reduction was coincidental with the
significant decrease of Alb-Au observed in glycocalyx at the same
time interval. So far, it may be derived that at 45 minutes the
endocytosis of Alb-Au may have been almost complete.
Although the number of coated vesicles found in both groups of
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Fig. 3. Parietalperitoneum 10 minutes after i.p. injection of Alb-A u. Mesothelial cell (c) showing particles of the tracer within a coated vesicle (open star)
in the cytoplasm (small straight arrows), as well as on the luminal plasmalemma (short curved arrow). Abbreviations are: p, peritoneal space; N, nucleus
of mesothelial cell (x 41500). Low left inset. Other area of the same mesothelial cell at higher magnification. Coated vesicles (asterisks) show Alb-Au
complexes (arrows), most of them adsorbed on the luminal aspect of the limiting membrane. Black star, peritoneal space; C, cytoplasm of mesothelial
cell (X 87000).
complexes
Alb-Au complexes in
junctional areas
(excluding
diaphragmatic stomata)
Alb-Au in diaphragrnatic 7 (0.38%)
stomata
Alb-Au in non-junctional 100 (5.44%)
areas
Non-junctional vs.
junctional Mb-Au (10
mm)
Non-junctional vs. —
junctional Alb-Au (45
mm)
Alh-Au in plasmalemmal
vesicles vs. those
observed in tight
junctions at 10 mm
Alb-Au in plasmalemmal —
vesicles vs. those
observed in tight
junctions at 45 miii
8 (0.83%)(2 = parietal1 = mesentery5 = diaphragm)
11(1.15%)
79 (8.23%) NS
— <0.05
Table 2. Alb-Au complexes in submesothelial interstitial tissue and in
mesothelial intercellular junctions and plasmalemmal vesicles
10 miii 45 miii P
Interstitial Alb-Au 107 (5.82%) 90 (9.38%) NS
4 (0.21%)(1 = parietal3 = diaphragm)
samples were similar, the proportion of Alb-Au complexes in-
cluded at 45 minutes (8.7%) was significantly higher (P < 0.01)
than that observed at 10 minutes (2.3%). As for plasmalemmal
vesicles, most particles of the tracer were attached to the luminal
aspect of the internal limiting membrane of coated vesicles (90%
at 10 mm, and 61.43% at 45 mm; NS). Few Alb-Au was
observed free in mesothelial cell cytoplasm. The proportions were
1.52% and 0.5% of total intracellular Alb-Au for the 10 and the 45
minute samples (P = NS).
Alb-Au complexes in the submesothelial interstitial tissue. As early
as 10 minutes after being injected, Alb-Au was noticed in the
submesothelial interstitial space lying between the cell and its
basement membrane (Figs. 1 and 2, inset), and even distant,
between collagen fibers located under the mesothelium (Fig. 2), as
well as among those adjacent to lymphatic capillaries (Fig. 4). The
mean distance separating interstitial Alb-Au complexes from
abluminal aspect of mesothelial cell plasmalemma was 0.27 0.26
jm (range 0,01 to 1.86 jim) at 10 minutes and 0.28 0.31 jim
(range 0.001 — 1.03 jim) for the 45 minute samples.
Ten minutes after intraperitoneal injection, almost 6% of the
total number of observed Alb-Au complexes found its way to the
submesothelial interstitial tissue. Very few of them appeared close
to junctional areas. At 45 minutes, the proportion of Alb-Au
complexes located within the interstitial compartment was higher
than that observed at 10 minutes, even though the difference did
NS
NS
5.44% vs. 0.59%
18.16% vs. 3.53%
8.23% vs. 1.15% <0.05
— <0.002
36.04% vs. 0.52% <0.001
Values between parentheses represent percentages of total number of
observed Alb-Au complexes.
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Fig. 4. Diaphragma tic peritoneum 10 minutes
after i.p. injection of Alb-Au complexes. The
black star calls attention to a stomata
communicating the peritoneal space (s) and the
submesothelial connective tissue (c). Alb-Au
complexes (large straight arrow) are present
immediately under the mesothelial cell (open
arrow), between collagen fibers (open circles),
as well as in the subendothelial interstitial space
(short straight arrows) of the lymphatic lacuna.
The curved arrow points at a particle of the
tracer included in an endothelial plasmalemmal
vesicle (e is lymphatic endothelial cell). (X
30740). Inset. Diaphragmatic mesothelium 10
mm after i.p. injection of Alb-Au complexes.
Arrow indicates an endosome containing Aib-
Au complexes. Abbreviations and symbols are:
s, peritoneal space; , mesothelial cell
cytoplasm; black stars, plasmalemmal vesicles;
open star, submesothelial basement membrane;
i, interstitial space (X 64550).
not reach statistical significance (Table 2). Here again, less than
10% of the observed Alb-Au was adjacent to junctional areas. It
should be noted that at both time intervals, percentages of
non-junctional interstitial Alb-Au complexes were significantly
higher than those appearing close to the abluminal side of
intercellular junctions (Table 2).
Morphologically, intermesothelial cell gaps of diaphragmatic
stomata appeared as open pathways for Mb-Au complexes (Fig.
4), even though their capability of delivering particles of the tracer
to the lymphatic system did not seem much higher than that
shown by non-stomata! mesothelial junctions (Table 2). On the
whole, it can be inferred from the last two statistical comparisons
presented in Table 2 that the proportion of Alh-Au complexes
observed into plasmalemmal vesicles is significantly higher than
that found within intermesothelial cell junctions.
Diaphragmatic lymphatic capillaries
Microvascular lumen, glycocalyx and interendothelial cell junc-
tions. Comparison of the total number of Mb-Au complexes
within the microvascular lumen as well as that of particles
observed per micron of lumina! glycocalyx in samples obtained at
10 and 45 minutes did not show significant differences. Modest
and almost much the same proportions of Alb-Au complexes were
observed passing through open interendothelial cell junctions at
both intervals (Fig. 5; 3.88% at 10 mm vs. 2.59% at 45 mm; P
NS).
The interstitial density of the tracer appeared significantly
higher in the 10 minute samples, whereas most of it was distrib-
uted along non-junctional areas of the endothelial abluminal
aspect (Table 2).
The presence of Alb-Au complexes in plasmalemmal vesicles and
multivesicular bodies of lymphatic endothelial cells. Endothelial
cells of lymphatic capillaries showed plasmalemmal vesicles, the
total number and topographic distribution of which, at both time
intervals, were not significantly different (data not shown).
Approximately one fifth of those vesicles contained Alb-Au
complexes that were infrequently seen attached to the vesicle
luminal limiting membrane (Fig. 4). Mostly the tracer appeared
I
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Fig. 5. Diaphragmatic submesothelial lymphatic capilla,y 10 mm after i.p. injection of Alb-Au complexes). Left inset. Alb-Au complexes (long arrow) can
he observed in their pathway through an open interendothelial cell junction (open Star). More particles of the tracer are seen (open circles) within the
luminal space (1) of the microvessel. Arrowhead points to Alb-Au included into a plasmalcmmal vesicle (i is the subendothelial interstitium) (X 41500).
Right inset. Lymphatic capillary endothelial cell (e). Alb-Au complexes appear into an endosome (b) as well as into a plasmalemmal vesiclc (straight
arrow). Curved arrow points at Alb-Au complexes present in the interstitium (i). Notice the absence of subendothelial basement membrane (X 64550).
Table 3. Distribution of Alb-Au complexes within the lumen, along the
glycocalyx, in interendothelial cell junctions and interstitium of
diaphragmatic lymphatic capillaries, at 10 and 45 minutes after i.p.
injection of the tracer
10 mm 45 mm p
Alb-Au in 41(17.67%) 7 (3.65%) <0.01
subendothelial
interstitium
Percentage of interstitial 87.20% 100% NS
Alb-Au located in
non-junctional areas
Alb-Au in junctions vs.
Alb-Au
in PV (percentages of 3.88% vs. 24.35% — <0.001
total
Alb-Au counted — 2.59% vs. 18.48% <0.001
complexes)
Numbers between parentheses represent percentages of the total
number of Alb-Au complexes observed in diaphragmatic lymphatics,
unless otherwise specified.
free within the lumen of plasmalemmal vesicles (Fig. 5). There
were no significant differences in density of labeling and topogra-
phy of plasmalemmal vesicles, comparing data obtained at 10 and
45 minutes (data not shown). The proportion of Alb-Au com-
plexes detected within plasmalemmal vesicles was significantly
Table 4. Plasmalemmal vesicles in endothelial cells of diaphragmatic
lymphatic capillaries
10 mm 45 mm p
Mb-Au complexes within PV 56 (24.35%) 39 (18.48%) NS
PV containing Alb-Au complexes 39 (16.96%) 15 (7.11%) <0.01
Alb-Au adsorbed on luminal 17.83% 15.28% NS
aspect of PV internal limiting
membrane
Alb-Au_complexes in MVB 77 (33.19%) 98_(51.04%)__<0.001
Values between parentheses represent percentages of total counts of
Alb-Au complexes.
higher than those observed into interendothelial cell junctions at
both time intervals (Table 3). Percentages of Alb-Au containing
plasmalemmal vesicles were substantially higher in the 10 minute
samples (Table 4).
Hence, multivesicular bodies (Figs. 4 and 6, inset) or endo-
somes containing Alb-Au complexes (Fig. 5, inset) were more
frequently observed in samples obtained at 45 minutes (Table 4).
At times, those organdies were noticed occupying most of the
endothelial cell width. On a small scale, transcellular channels
carrying Alb-Au complexes at times were observed connecting,
apparently, the subendothelial interstitium with the microvascular
lumen. Very occasionally (less than 0.1% of total counts), some
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Fig. 6. This post-capillary venule was observed in a sample of mesentely taken from a mouse 45 minutes after intraperitoneal injection of Alb-Au. The
intercellular junction (*) occurs between two adjacent endothelial cells (e). Alb-Au can be seen (arrowhead) adsorbed on the limiting membrane of a
plasmalemmal vesicle (v) open on the microvascular lumen (1). The perithelial cell (p) shows plasmalemmal vesicles containing Alb-Au particles
(arrows). Alb-Au is also visible (open star) in the subperithelial interstitial space (i) (x 33557). Inset. This micrograph of a lymphatic mesenteric
capillaty was taken on a sample obtained 45 minutes after intraperitoneal injection of Alb-Au. A multivesicular body (b) containing particles of Alb-Au
(arrows) occupies a large part of the endothelial cell (e) thickness. Abbreviations are: I, microvascular lumen; i, interstitial space < 87000).
Alb-Au complexes were observed free in the endothelial cell
cytoplasm.
It should be emphasized that endothelial cells of blood capil-
laries observed in peritoneal samples obtained 10 minutes after
injection of Alb-Au were in no instance decorated by particles of
the tracer. Conversely, at 45 minutes Alb-Au complexes were
present in plasmalemmal vesicles of blood capillary endothelium
as well as in those located in perithelial cells of post-capillary
venules. By the same time, Alb-Au complexes appeared in the
interstitial tissue adjacent to blood microvessels (Fig. 6).
Discussion
The actual pathways and mechanisms by which macromolecular
transport across microvascular endothelium and mesothelium
occurs still remain to be identified. Some 50 years ago, it was
suggested that junctions between capillary endothelial cells should
be considered the main pathway for exchanges across the micro-
vascular wall [221. This concept was later on extended to the
peritoneum, and was extensively analyzed within the frame of the
one pore [23], the two pore [24, 25], and lately the three pore [26]
size models of capillary and/or peritoneal permeability. The fact
that these models failed to completely explain experimental data
regarding the microvascular permeability to macromolecules lead
some investigators to look for other possible mechanisms of
transendothelial transport [27]. Furthermore, to date the endo-
thelial and mesothelial postulated pores have not been convinc-
ingly identified. So, the existence of transcellular pathways via
shuttling [27], or fused plasmalemmal vesicles [28] forming short-
lived transendothelial channels [29—3 11 have been more recently
proposed to explain the passage of macromolecular plasma
proteins. Of course, both aforementioned mechanisms are not
necessarily exclusive.
Albumin gold complexes are large compounds which appar-
ently behave like polymerized albumin, and can be used as an
electron microscope probe for the long time predicted and still
unidentified large pore equivalent.
These complexes have been recently used for investigating
receptor mediated endocytosis of albumin in several microvascu-
lar endothelia [32—37]. This approach, applied to the mouse
mesentery, was expected to disclose whether injected Alb-Au
would eventually he absorbed from the peritoneal cavity, by a
process of endocytosis and, perhaps, transcytosis occurring
through mesothelial cells. In this context, our observations show
different moments of the process of transmesothelial absorption
of the tracer. Ten minutes after the intraperitoneal injection of
AIb-Au, the marker was present in coated pits and coated vesicles,
in plasmalemmal vesicles, as well as in multivesicular bodies and
endosomes of mesothelial cells.
Percentage of plasmalemmal vesicles carrying Alb-Au com-
plexes ranged between 17.4% at 10 minutes and 16.22% at 45
minutes. Those figures are quite close to the 16% observed by
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Fig. 7. Sample of rat diaphragmatic mesothelium taken 10 minutes after intraperitoneal injection of Alb-Au. The mesothelial cell (c) shows an endosome
(h) containing numerous particles of the tracer. Other particles can be seen (open circles) in the submesothelial interstitium (i). Black star is the
peritoneal space (X 64550). Inset. Other aspect of the same sample. Two abluminal plasmalemmal vesicles (black stars) were detected discharging
Alb-Au particles (black arrows) in the submesothelial interstitium (i), which shows one particle of the tracer (open star) well beyond the basement
membrane (*). Abbreviations are: S. peritoneal space; C, mesothelial cell (X 84530).
Milici et al [17] during receptor mediated transcytosis of mono-
meric albumin in mice myocardial capillary endothelium. This
similarity leads to a speculation about the possibility that in our
experiment, peritoneal absorption of the ligand took place mainly
transcellularly by both endocytosis and transcytosis. The former
mechanism would imply an active role of mesothelial cells in the
degradation of at least conformationally modified albumins, as
described by Schnitzer and Bravo [38]. The latter is also suggested
by images showing abluminal plasmalemmal vesicles discharging
Alb-Au complexes in the interstitial tissue separating the me-
sothelial cell from the subjacent basement membrane (Fig. 7).
It may be speculated that interstitial gold particles may even-
tually result from exocytosis of gold particles that have lost their
albumin coating by lysosomal degradation. However, the chances
are against this hypothesis since Milici et al [17] demonstrated
that BSA remained attached to gold particles throughout the
whole process of transcytosis through mice myocardial capillary
endothelium.
As shown in Table 2, the proportion of tracer present in
mesothelial junctions at 45 minutes was significantly higher than
that observed in the 10 minute specimens. This may be a
suggestion that a small percentage of Alb-Au reached the inter-
stitium through junctions, but at a quite slow pace. This is in
accordance with previous studies that demonstrated the existence
of dense labeling of anionic sites [39—41] in clefts of interme-
sothelial cells, as well as within the portals and cellular surfaces
bordering the stomatal openings [39], thus opposing the passage
of anionic albumin. In this sense, the apparently direct commu-
nication between the abdominal cavity with the diaphragmatic
lacunae and lymphatic capillaries [42] does not imply the existence
of an absolutely open and free pathway. The relevance of the
paracellular pathway is further diminished by the observation that
percentage of Mb-Au appearing in junctional interstitial areas
was remarkably lower than that detected in submesothelial tissue
far off from abluminal side of intercellular junctions (Table 2).
All this information suggests that absorption of the ligand took
place mainly transcellularly by both endocytosis and transcytosis.
The proportional contribution of each mechanism cannot be
evaluated. We do not yet know whether the interaction between
Alb-Au complexes and mesothelial plasmalemmal and vesicular
membranes is of a pure electrostatic nature or if it results from the
presence of specific albumin binding proteins similar to those
described in endothelial cells of mice capillaries obtained from
several microvascular beds [33, 34, 37, 38, 43].
Samples taken at 45 minutes showed Mb-Au complexes in
endothelial and perithelial cell vesicles of blood microvessels, as
well as in the pericapillary interstitial tissue (Fig. 6). Of course, the
information provided by the present experiments is insufficient to
conclude about the direction of the passage. However, it should
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be noted that 45 minutes elapsed since the intraperitoneal injec-
tion of the tracer which, on the other hand, was not observed in
blood capillary endothelium at 10 minutes. Therefore, it is
tempting to speculate that those Alb-Au complexes may well be
particles of the tracer which, after being absorbed by peritoneal
lymphatics, reached the mesentery again through the systemic
circulation.
It has been estimated that the amount of albumin absorbed
from the abdominal cavity through mesenteric lymphatics repre-
sents a quite small proportion of the whole peritoneal absorption
[1 1]. However, our observations, together with the fact that
mesenteric peritoneum makes up approximately 15% of the
peritoneal surface [44], suggest that albumin absorption through
mesenteric mesothelium appears to be substantially higher than
previously thought. A similar deduction can be extended to
parietal peritoneum, on the basis of the observations made on
mesothelial cells covering the cavitary aspect of the abdominal
cavity.
The present study suggests that mesothelial and capillary
lymphatic endothelial cells are actively involved in the process of
a pathway, which appears to be transcytosis by means of plasmale-
mmal vesicles and, at a minor degree, coated vesicles. If so, these
organelles may well represent the equivalent of the postulated
large pore. The fact that a few Alb-Au carrying transcellular
channels were detected in lymphatic endothelium is a suggestion
that this path, which is supposed to provide the convective
component of the transcellular transport of large (>10 nm)
solutes [17], is a minor element of the transendothelial transport
system of the tracer.
Our findings also support the theory of vesicular transport for
absorption of albumin, at least for the mesothelium and lymphatic
endothelium [45]. The eventual role of intra-abdominal hydro-
static pressure within the range of values observed in clinical
peritoneal dialysis [46], upon this specific process of albumin
absorption [7, 10—13] by endocytosis and transcytosis, is still
unclear [47]. The relevance of intermesothelial cell junctions
seems to be minor, although this path can eventually become
highly permeable to anionic plasma proteins during the acute
inflammatory reaction. Under these circumstances, tight junctions
appear to be wide open [48, 49], whereas the density of subme-
sothelial anionic sites is substantially reduced [50].
This situation of having the mesothelium playing an active and
vital role in the absorption from the peritoneal cavity [2] raises the
possibility of modulating this process by means of pharmacologi-
cal agents acting at the molecular level.
Finally, the active involvement of mesothelium, similar to that
observed in vascular endothelial monolayers [51], supplemented
to the lack of subendothelial lymphatic anionic sites, could be an
additional explanation of the postulated asymetry in the bidirec-
tional transport of macromolecules from blood to the peritoneal
cavity, and from the cavity through the lymphatic system back to
blood [12, 52].
Reprint requests to Lazaro Gotloib, M.D., Department of Nephrology,
Central Emek Hospital, Afula 18101, Israel.
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